156 related articles for article (PubMed ID: 34612613)
1. Catecholamines in neuroblastoma: Driver of hypertension, or solely a marker of disease?
Harding M; Deyell RJ; Blydt-Hansen T
Cancer Rep (Hoboken); 2022 Aug; 5(8):e1569. PubMed ID: 34612613
[TBL] [Abstract][Full Text] [Related]
2. Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrine.
Peitzsch M; Butch ER; Lovorn E; Mangelis A; Furman WL; Santana VM; Hero B; Berthold F; Shulkin BL; Huebner A; Eisenhofer G
Pediatr Blood Cancer; 2020 Feb; 67(2):e28081. PubMed ID: 31724812
[TBL] [Abstract][Full Text] [Related]
3. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
Candito M; Thyss A; Albertini M; Deville A; Politano S; Mariani R; Chambon P
Med Pediatr Oncol; 1992; 20(3):215-20. PubMed ID: 1574031
[TBL] [Abstract][Full Text] [Related]
4. A metanephrine test for a screening of catecholamine-producing tumors.
Sato T; Yoshinaga K
Tohoku J Exp Med; 1973 Jul; 110(3):283-7. PubMed ID: 4757670
[No Abstract] [Full Text] [Related]
5. [Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. 2. Clinical studies on urinary metanephrine and normetanephrine in patients with pheochromyocytoma and a patient with neuroblastoma].
Shimbo S
Naika Hokan; 1968 Sep; 15(9):299-310. PubMed ID: 5752086
[No Abstract] [Full Text] [Related]
6. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
Candito M; Soler C; Deville A; Bekri S; Chambon P; Thyss A
Med Pediatr Oncol; 1996 Jan; 26(1):57-60. PubMed ID: 7494513
[TBL] [Abstract][Full Text] [Related]
7. Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients.
Verly IR; van Kuilenburg AB; Abeling NG; Goorden SM; Fiocco M; Vaz FM; van Noesel MM; Zwaan CM; Kaspers GL; Merks JH; Caron HN; Tytgat GA
Eur J Cancer; 2017 Feb; 72():235-243. PubMed ID: 28061374
[TBL] [Abstract][Full Text] [Related]
8. Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice.
Smith SJ; Diehl NN; Smith BD; Mohney BG
Eye (Lond); 2010 Dec; 24(12):1792-6. PubMed ID: 20865029
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a paediatric age-related reference interval for the measurement of urinary total fractionated metanephrines.
Griffin A; O'Shea P; FitzGerald R; O'Connor G; Tormey W
Ann Clin Biochem; 2011 Jan; 48(Pt 1):41-4. PubMed ID: 21123298
[TBL] [Abstract][Full Text] [Related]
10. N-acetylnormetanephrine and N-acetylmetanephrine in urine from patients with neuroblastoma.
Borud O; Gjessing LR
Clin Chim Acta; 1970 Mar; 27(3):552-4. PubMed ID: 4190912
[No Abstract] [Full Text] [Related]
11. Adrenergic crisis as a debut form of a neuroblastoma.
Alonso Cadenas JA; Almodóvar Martín JL; Iglesias Bouzas MI; Jiménez García R; Serrano González A
Rev Chil Pediatr; 2020 Oct; 91(5):767-772. PubMed ID: 33399643
[TBL] [Abstract][Full Text] [Related]
12. Catecholamine measurements in pheochromocytoma and neuroblastoma.
Spiegel HE
Ann Clin Lab Sci; 1974; 4(3):174-7. PubMed ID: 4363482
[No Abstract] [Full Text] [Related]
13. Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites.
Miano L; Kolloch R; De Quattro V
Clin Chim Acta; 1979 Jul; 95(2):211-7. PubMed ID: 527220
[TBL] [Abstract][Full Text] [Related]
14. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
[TBL] [Abstract][Full Text] [Related]
15. The VMA test strip: a new tool for mass screening, diagnosis, and management of catecholamine-secreting tumors.
Leonard AS; Roback SA; Nesbit ME; Freier E
J Pediatr Surg; 1972; 7(5):528-31. PubMed ID: 4673371
[No Abstract] [Full Text] [Related]
16. The urinary excretion of catecholamines and their derivatives in primary hypertension in man.
Bing RF; Harlow J; Smith AJ; Townshend MM
Clin Sci Mol Med; 1977 Mar; 52(3):319-23. PubMed ID: 557404
[TBL] [Abstract][Full Text] [Related]
17. Disparate urinary catecholamine patterns in secondary hypertension due to unique sequential development of pheochromocytoma and neuroblastoma.
Amodeo C; Perez J; Sturgill BC; Turner SM; Atuk NO
Arch Pathol Lab Med; 1989 Jul; 113(7):800-2. PubMed ID: 2742460
[TBL] [Abstract][Full Text] [Related]
18. Association Between Urinary Catecholamine Excretion and Urine Volume.
Haap M; Blaschka F; Lehmann R; Hoyer A; Müssig K
Horm Metab Res; 2019 Aug; 51(8):531-538. PubMed ID: 31174227
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of urinary N-acetyldopamine as a marker for neuroblastomas: comparison with traditional urinary catecholamine metabolites.
Muskiet FA; Kema IP
J Chromatogr; 1992 Aug; 579(1):184-6; discussion 187-8. PubMed ID: 1447347
[No Abstract] [Full Text] [Related]
20. Plasma free metanephrines for diagnosis of neuroblastoma patients.
Barco S; Verly I; Corrias MV; Sorrentino S; Conte M; Tripodi G; Tytgat G; van Kuilenburg A; van der Ham M; de Sain-van der Velden M; Garaventa A; Cangemi G
Clin Biochem; 2019 Apr; 66():57-62. PubMed ID: 30822416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
